首页> 外文期刊>Malaria Journal >Malaria testing and treatment knowledge among selected rural patent and proprietary medicine vendors (PPMV) in Nigeria
【24h】

Malaria testing and treatment knowledge among selected rural patent and proprietary medicine vendors (PPMV) in Nigeria

机译:尼日利亚部分农村专利和专有药品供应商(PPMV)中的疟疾测试和治疗知识

获取原文
           

摘要

Abstract BackgroundMalaria is a leading cause of illness and death in Nigeria, but access of poor people to quality anti-malarial services remains low especially in the rural areas. Patent and proprietary medicine vendors (PPMVs) provide the majority of malaria treatment in rural areas, but little is known about their knowledge of malaria testing and treatment of uncomplicated malaria as recommended in the 2011 National Malaria Control Programme policy.MethodsA cross-sectional survey was conducted in two purposively selected states (Oyo and Bayelsa) in Nigeria with each state representing a different geographic and linguistic–ethnic region in the southern part of the country. Two rural LGAs were randomly selected from each state and data were collected from 160 randomly selected PPMVS (40 per LGA) using a structured questionnaire. Data were analysed using descriptive statistics.ResultsThe 2011 National Policy on Malaria Diagnosis and Treatment is mostly unknown to PPMVs. Although most PPMVs (89%) knew that artemisinin-based combination therapy (ACT) is recommended in the national policy, 91% also thought non-ACT were endorsed. The proportion of PPMVs who stated they would treat a malaria case with an artemisinin-based combination at the correct dose was 33% for a child under five, 47% for an adult male and 14% for a pregnant woman in her second trimester. The proportion of PPMVs who reported they would diagnose a case of malaria prior to treatment using a malaria rapid diagnostic test (RDT) kit was 1.9% for children under five, 7.5% for adult males and 3.1% for pregnant women in their first trimester due to lack of knowledge. Almost two-thirds (65.6%) would correctly refer children with severe malaria to health facility.ConclusionsSubstantial knowledge gaps on the use of RDTs and treatment with artemisinin-based combinations exist among rural PPMVs. Given existing evidence regarding the effectiveness of private retail outlets in malaria case management, PPMVs should be provided with competency-based training and supervision to improve the quality of care they provide.
机译:摘要背景疟疾是尼日利亚疾病和死亡的主要原因,但贫困人口获得优质抗疟疾服务的机会仍然很低,特别是在农村地区。专利和专有药品销售商(PPMV)在农村地区提供了大多数的疟疾治疗方法,但根据2011年《国家疟疾控制计划》政策的建议,他们对疟疾检测和单纯性疟疾治疗的知识知之甚少。在尼日利亚的两个故意选择的州(奥约州和巴耶尔萨州)进行,每个州代表该国南部不同的地理和语言族裔地区。从每个州随机选择两个农村地方政府贷款,并使用结构化问卷从160个随机选择的PPMVS(每个LGA 40个)中收集数据。结果使用PPMV对2011年国家疟疾诊断和治疗政策知之甚少。尽管大多数PPMV(89%)都知道在国家政策中推荐使用青蒿素类联合疗法(ACT),但91%的人也认为非ACT被认可。表示他们将以正确剂量的青蒿素为基础的组合治疗疟疾的PPMV的比例为五岁以下儿童为33%,成年男性为47%,孕中期为14%。报告称在五岁以下儿童中使用疟疾快速诊断测试(RDT)试剂盒诊断出疟疾之前,PPMV的比例为1.9%(五岁以下儿童),7.5%(成年男性)和3.1%(孕妇)。缺乏知识。将近三分之二(65.6%)的人将正确地将患有严重疟疾的儿童转诊至医疗机构。结论农村PPMV中存在使用RDT和以青蒿素为基础的联合疗法治疗方面的大量知识空白。鉴于现有证据表明私人零售店在疟疾病例管理方面的有效性,应当为PPMV提供基于能力的培训和监督,以提高其提供的护理质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号